糖尿病指南:如何预防二型糖尿病Prevention/Delay of Type 2 Diabetes
Patients with IGT, IFG, or A1C 5.7%-6.4%
Refer to ongoing support program targeting
Patients with IGT, IFG, or A1C 5.7%-6.4%
Refer to ongoing support program targeting
• Weight loss (7% of body weight)
• Increased physical activity (≥150 min/week moderate activity)
Consider metformin therapy for type 2 diabetes prevention in patients with IGT, IFG, or A1C 5.7%-6.4%
Especially in presence of
• BMI >35 kg/m2
• Age
• Women with prior GDM
Annual monitoring of individuals with prediabetes
Screening for and treatment of modifiable CVD risk factors(obesity, hypertension, and dyslipidemia) suggested
BMI=body mass index; CVD=cardiovascular disease; GDM=gestational diabetes mellitus; IFG=impaired fasting glucose; IGT=impaired glucose tolerance